Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Inhibikase Therapeutics, Inc. (IKT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8500+0.0050 (+0.59%)
At close: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/24/2022
Current
6/30/20223/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
21.44M18.73M37.34M36.98M47.79M70.37M
Enterprise Value
-19.06M-21.77M-3.17M-7.62M1.21M62.01M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/A11.3952.9416.0315.35
Price/Book (mrq)
0.730.550.970.861.028.76
Enterprise Value/Revenue
N/AN/AN/AN/A3.6845.49
Enterprise Value/EBITDA
1.014.690.681.51-0.27-23.59

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-55.29%
S&P500 52-Week Change 3-16.03%
52 Week High 32.3400
52 Week Low 30.6000
50-Day Moving Average 30.8836
200-Day Moving Average 31.1104

Share Statistics

Avg Vol (3 month) 3264.57k
Avg Vol (10 day) 396.08k
Shares Outstanding 525.23M
Implied Shares Outstanding 6N/A
Float 818.28M
% Held by Insiders 121.32%
% Held by Institutions 119.55%
Shares Short (Aug 30, 2022) 4470.34k
Short Ratio (Aug 30, 2022) 40.77
Short % of Float (Aug 30, 2022) 42.37%
Short % of Shares Outstanding (Aug 30, 2022) 41.86%
Shares Short (prior month Jul 28, 2022) 477.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,906.98%

Management Effectiveness

Return on Assets (ttm)-28.23%
Return on Equity (ttm)-49.10%

Income Statement

Revenue (ttm)382.99k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-99.50%
Gross Profit (ttm)-8.26M
EBITDA N/A
Net Income Avi to Common (ttm)-18.79M
Diluted EPS (ttm)-0.7630
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.21M
Total Cash Per Share (mrq)1.28
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.56
Book Value Per Share (mrq)1.17

Cash Flow Statement

Operating Cash Flow (ttm)-14.41M
Levered Free Cash Flow (ttm)-7.69M
Advertisement
Advertisement